Merck and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration

Strategic academic-industry alliance aims to build robust Research & Development talent pipeline

29-Jul-2025

Merck has signed a non-binding Memorandum of Understanding (MoU) with Washington University (WashU) in St. Louis, Missouri, USA. The agreement marks the next chapter in a nearly century-long partnership dedicated to advancing scientific research and innovation.

Merck KGaA

Merck signs non-binding MoU with Washington University in St. Louis. The agreement continues their nearly century-long partnership.

The expanded collaboration will support joint research initiatives, technology scouting, and research enablement, with an emphasis on fostering sustainable and socially responsible scientific progress. Together, Merck and WashU aim to strengthen the talent pipeline, accelerate the transition from lab discoveries to clinical applications, and help eventually bring life-saving therapies to patients faster.

“Academic-industry collaborations are more critical than ever in today’s dynamic scientific landscape,” said Jean-Charles Wirth, Member of the Executive Board of Merck and CEO, Life Science. “Our partnership with WashU underscores Merck’s commitment to empower the next generation of scientists driving progress in healthcare and the life sciences. By combining WashU's world-class research capabilities with our advanced technologies and industry expertise, we can fuel innovation with lasting impact.”

“This agreement represents a new milestone in the shared history of WashU and Merck,” said WashU Chancellor Andrew D. Martin. “Collaboration is central to our university’s research and scientific success. Partnering with an industry leader like Merck will expand our capacity to generate solutions to the world’s greatest challenges.” 

Through the partnership, Merck will provide access to its broad portfolio of products, services, and technical expertise, helping researchers innovate more efficiently and effectively. The MoU also expands Merck’s efforts to support early-stage innovation by engaging with startups and incubators, offering emerging ventures resources and services tailored to accelerate their growth.

WashU’s campus is located near Merck’s network of production and R&D sites in St. Louis where the company employs nearly 2,300 people. Over the last five years, Merck has invested more than $250 million in its St. Louis operations, further strengthening its regional footprint and advancing local scientific capabilities. The MoU reinforces Merck’s continued commitment to the St. Louis innovation ecosystem and its broader mission to positively impact more lives through science.

This agreement reflects Merck’s commitment to deepening ties with leading universities around the world to advance research, support scientific talent, and help bring new ideas to life. By fostering strong collaborations, Merck aims to create more opportunities for discovery and real-world impact.

Other news from the department research and development

Most read news

More news from our other portals

So close that even
molecules turn red...

Last viewed contents

WACKER and start-up Gearbox Biosciences announce strategic collaboration - The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA)

WACKER and start-up Gearbox Biosciences announce strategic collaboration - The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA)

Cannovum Health welcomes new strategic majority investor

Cannovum Health welcomes new strategic majority investor

Dr. Wolf-Henning Walther becomes new CEO at Metrohm Germany - Change in the Executive Board from September 1, 2025

Dr. Wolf-Henning Walther becomes new CEO at Metrohm Germany - Change in the Executive Board from September 1, 2025

Norgine completes acquisition of Theravia

Norgine completes acquisition of Theravia

New method loads mRNA into exosomes in 10 minutes—just mix and go - KIST team develops cubosome-based method for loading large therapeutics without damaging exosomes

New method loads mRNA into exosomes in 10 minutes—just mix and go - KIST team develops cubosome-based method for loading large therapeutics without damaging exosomes

Reduced genome – flexible performance: How symbiotic bacteria with minimal genetic information support their host - Despite having only a tiny genome, the symbionts of reed beetles can adapt their gene activity flexibly to the developmental stages and ambient temperatures of their hosts

Reduced genome – flexible performance: How symbiotic bacteria with minimal genetic information support their host - Despite having only a tiny genome, the symbionts of reed beetles can adapt their gene activity flexibly to the developmental stages and ambient temperatures of their hosts

Insights into olfactory disorders in Alzheimer's disease

Insights into olfactory disorders in Alzheimer's disease

Ultrasound could deliver drugs with fewer side effects

Ultrasound could deliver drugs with fewer side effects

Using bacteria to sneak viruses into tumors - The bioengineered platform enables a cancer-killing virus to evade the patient’s immune system — and prevents it from spreading throughout the body.

Using bacteria to sneak viruses into tumors - The bioengineered platform enables a cancer-killing virus to evade the patient’s immune system — and prevents it from spreading throughout the body.

The diamonds that could find cancer - Endoscopic diamond magnetometer for cancer surgery

The diamonds that could find cancer - Endoscopic diamond magnetometer for cancer surgery

Stora Enso’s billion-euro investment in renewable packaging - Europe's most modern consumer board production line inaugurated in Finland

Stora Enso’s billion-euro investment in renewable packaging - Europe's most modern consumer board production line inaugurated in Finland

Sensing sour: How SNAP25 powers taste signals and keeps sensory cells alive - SNAP25 enables sour taste perception by supporting both signal transmission and the long-term survival of type III taste cells

Sensing sour: How SNAP25 powers taste signals and keeps sensory cells alive - SNAP25 enables sour taste perception by supporting both signal transmission and the long-term survival of type III taste cells